Emerald Mutual Fund Advisers Trust’s Wave Life Sciences WVE Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.91M	Sell	814,529 -600,136	-42%	-$7.82M	0.29%	106
2025 Q4	$24M	Sell	1,414,665 -351,397	-20%	-$3.57M	1.17%	23
2025 Q3	$12.9M	Sell	1,766,062 -171,427	-9%	-$1.39M	0.67%	62
2025 Q2	$12.6M	Buy	1,937,489 +6,669	+0.3%	+$44K	0.77%	48
2025 Q1	$15.6M	Sell	1,930,820 -214	-0%	-$2.34K	1.11%	35
2024 Q4	$23.9M	Sell	1,931,034 -192,432	-9%	-$2.57M	1.45%	14
2024 Q3	$17.4M	Buy	2,123,466 +302,528	+17%	+$1.81M	0.9%	43
2024 Q2	$9.09M	Buy	+1,820,938	New	+$10.4M	0.48%	77

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's WVE Position: Q1 2026 in Review

Emerald Mutual Fund Advisers Trust reduced its Wave Life Sciences (WVE) stake by 42% in Q1 2026, selling an estimated $7.82M and leaving 814,529 shares worth $5.91M. The position accounts for 0.29% of the portfolio, ranked #106.

Emerald Mutual Fund Advisers Trust first reported a position in WVE in Q2 2024 and has held it in 8 quarters since. The position peaked at $24M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Emerald Mutual Fund Advisers Trust held 814,529 shares of Wave Life Sciences worth $5.91M as of Q1 2026.
Emerald Mutual Fund Advisers Trust sold 600,136 Wave Life Sciences shares in Q1 2026, an estimated $7.82M.
Wave Life Sciences made up 0.29% of Emerald Mutual Fund Advisers Trust's portfolio in Q1 2026, its #106 holding.
Emerald Mutual Fund Advisers Trust first reported a position in Wave Life Sciences in Q2 2024 and has held it in 8 quarters since.
Emerald Mutual Fund Advisers Trust's Wave Life Sciences position peaked at $24M in Q4 2025.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2026, filed 4 May 2026.